Structure via PubChem · Public domain (PubChem)
mefloquine
Sign in to saveAlso known as WR-142490, GNF-Pf-5544, alpha-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol, [(R*,S*)-2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol, Ro-215998, Lariam, Mefloquin, Mefloquina
Mefloquine, sold under the brand name Lariam among others, is a medication used to prevent or treat malaria. When used for prevention it is typically started before potential exposure and continued for several weeks after potential exposure. It can be used to treat mild or moderate malaria but is not recommended for severe malaria. It is taken by mouth.
Key facts
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 458774403
- Drug.image
- Mefloquine chemical structure.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 185px
- Drug.tradename
- Lariam, Mephaquin, Mefliam, others
- Drug.MedlinePlus
- a603030
- Drug.DailyMedID
- Mefloquine
- Drug.pregnancy_AU
- B3
- Drug.routes_of_administration
- Oral
- Drug.class
- Antimalarial
- Drug.ATC_prefix
- P01
- Drug.ATC_suffix
- BC02
- Drug.legal_AU
- S4
- Drug.legal_CA
- Rx-only
- Drug.legal_UK
- POM
- Drug.legal_US
- Rx-only
via Wikipedia infobox
Chemical data
- Formula
- C17H16F6N2O
- Molecular weight
- 378.31 g/mol
- IUPAC name
- [2,8-bis(trifluoromethyl)quinolin-4-yl]-piperidin-2-ylmethanol
- SMILES
- C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O
- InChIKey
- XEEQGYMUWCZPDN-UHFFFAOYSA-N
- XLogP
- 3.6
- Polar surface area
- 45.2 Ų
- H-bond donors
- 2
- H-bond acceptors
- 9
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 1989
- Admin. routes
- oral
- Indications
- malaria, Plasmodium falciparum malaria, progressive multifocal leukoencephalopathy, urinary schistosomiasis
via ChEMBL · EBI
Research
3,628 papers- Mefloquine as a prophylaxis for malaria needs to be revisited.International journal for parasitology. Drugs and drug resistance · 2021
- Cellular targets of mefloquine.Toxicology · 2021
- Review of the mechanism underlying mefloquine-induced neurotoxicity.Critical reviews in toxicology · 2021
- Mefloquine.BMJ (Clinical research ed.) · 1994
- Mefloquine for malaria prophylaxis in military personnel.BMJ military health · 2020
via PubMed
Wikidata facts
- Subclass of
- heterocyclic compound
- Mass
- 378.116682
- Has use
- medication
Show 8 more facts
- Commons category
- Mefloquine
- chemical formula
- C₁₇H₁₆F₆N₂O
- significant drug interaction
- droperidol
- World Health Organisation international non-proprietary name
- mefloquine
- medical condition treated
- malaria
- canonical SMILES
- C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O
- defined daily dose
- 1
- subject has role
- malaria prophylaxis
Sources (6)
via Wikidata · CC0
~15 min read
Encyclopedic overview
20 sectionsContents
- Medical uses
- Malaria prevention
- Malaria treatment
- Resistance to mefloquine
- Contraindications
- Pregnancy and breastfeeding
- Adverse effects
- Neurologic and psychiatric
- Cardiac
- Pharmacology
- Pharmacodynamics
- Off-target activities
- Pharmacokinetics
- Chemistry
- History
- Military
- Research
- References
- Further reading
- External links
Mefloquine, sold under the brand name Lariam among others, is a medication used to prevent or treat malaria. When used for prevention it is typically started before potential exposure and continued for several weeks after potential exposure. It can be used to treat mild or moderate malaria but is not recommended for severe malaria. It is taken by mouth.
Common side effects include vomiting, diarrhea, headaches, sleep disorders, and a rash. Serious side effects include potentially long-term mental health problems such as depression, hallucinations, and anxiety and neurological side effects such as poor balance, seizures, and ringing in the ears. It is therefore not recommended in people with a history of mental health problems or epilepsy. It appears to be safe during pregnancy and breastfeeding.
Excerpted from Wikipedia’s “mefloquine” article, available under the CC BY-SA 4.0 licence.